Skip to main content
Clinical Trials/NCT03773614
NCT03773614
Completed
Not Applicable

Impairing Drugs and Alcohol as Risk Factors for Traumatic Injuries - a National Study on Injury Prevention

Oslo University Hospital1 site in 1 country5,000 target enrollmentMarch 1, 2019
ConditionsTrauma Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Trauma Injury
Sponsor
Oslo University Hospital
Enrollment
5000
Locations
1
Primary Endpoint
Presence of impairing illicit and medicinal drugs in blood samples.
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Impairing drugs and alcohol are major risk factors for traumatic injuries. Still there is to date little knowledge to what extent these factors affect the epidemiology of trauma. Detailed mapping of risk factors improve targeting and efficiency of primary injury prevention. The aim of this project is therefore to facilitate injury prevention through improved data collection and analysis on impairing drugs and alcohol as a contributing and modifiable factor in injury morbidity and mortality.

Study question: What is the toxicological profile among patients with suspected severe traumatic injury? Study design: a prospective population-based and national observational study will analyse toxicology from blood samples of all trauma admission during a 12 month study period.

Registry
clinicaltrials.gov
Start Date
March 1, 2019
End Date
February 29, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Thomas Kristiansen

Principal Investigator

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • admission to any Norwegian Trauma Hospital (n=37) AND trauma team activation, during study period

Exclusion Criteria

  • foreign citizens

Outcomes

Primary Outcomes

Presence of impairing illicit and medicinal drugs in blood samples.

Time Frame: Blood sample are collected at time of hospital admission for each participant. There is only one sample taken from each participant. Samples are consecutively analyzed during the study period.

Impairing substances are reported as nanogram per milliliter. Analysis is performed using liquid chromatography coupled with mass spectrometry.

Presence of alcohol in blood samples.

Time Frame: Blood sample are collected at time of hospital admission for each participant. There is only one sample taken from each participant. Samples are consecutively analyzed during the study period. The database is analyzed after study period is completed.

Alcohol is reported in grams per liter. Analysis of alcohol is performed with an automated enzymatic method using alcohol dehydrogenase.

Study Sites (1)

Loading locations...

Similar Trials